146 related articles for article (PubMed ID: 29131561)
1. Did Medicare Induce Pharmaceutical Innovation?
Acemoglu D; Cutler D; Finkelstein A; Linn J
Am Econ Rev; 2006 May; 96(2):103-7. PubMed ID: 29131561
[No Abstract] [Full Text] [Related]
2. Drug launch curves in the modern era.
Robey S; David FS
Nat Rev Drug Discov; 2017 Jan; 16(1):13-14. PubMed ID: 27910876
[No Abstract] [Full Text] [Related]
3. Biopharmaceutical benchmarks--2003.
Walsh G
Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
[No Abstract] [Full Text] [Related]
4. Pharmaceuticals in U.S. health care: determinants of quantity and price.
Berndt ER
J Econ Perspect; 2002; 16(4):45-66. PubMed ID: 15179978
[No Abstract] [Full Text] [Related]
5. The biotech drug market.
Lawrence S
Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
[No Abstract] [Full Text] [Related]
6. Does Increased Spending on Pharmaceutical Marketing Inhibit Pioneering Innovation?
Arnold DG; Troyer JL
J Health Polit Policy Law; 2016 Apr; 41(2):157-79. PubMed ID: 26732315
[TBL] [Abstract][Full Text] [Related]
7. Key factors in the rising cost of new drug discovery and development.
Dickson M; Gagnon JP
Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
[No Abstract] [Full Text] [Related]
8. Recombinant protein therapeutics--success rates, market trends and values to 2010.
Pavlou AK; Reichert JM
Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
[No Abstract] [Full Text] [Related]
9. Pipelines turn to biotech.
Lawrence S
Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
[No Abstract] [Full Text] [Related]
10. Biotech drug market steadily expands.
Lawrence S
Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
[No Abstract] [Full Text] [Related]
11. The latest trends in the pharmaceutical market.
Teitelbaum F
Case Manager; 2000; 11(5):70-4. PubMed ID: 11935588
[No Abstract] [Full Text] [Related]
12. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?
Preziosi P
Nat Rev Drug Discov; 2004 Jun; 3(6):521-6. PubMed ID: 15173841
[No Abstract] [Full Text] [Related]
13. The role of the pharmaceutical industry in drug development in dermatology.
Cauwenbergh G
Clin Dermatol; 2002; 20(5):467-73. PubMed ID: 12435516
[No Abstract] [Full Text] [Related]
14. 2004 approvals: the demise of the blockbuster?
Frantz S
Nat Rev Drug Discov; 2005 Feb; 4(2):93-4. PubMed ID: 15756752
[No Abstract] [Full Text] [Related]
15. Biopharmaceutical benchmarks 2006.
Walsh G
Nat Biotechnol; 2006 Jul; 24(7):769-76. PubMed ID: 16841057
[TBL] [Abstract][Full Text] [Related]
16. New drug development in the United States from 1963 to 1999.
Dimasi JA
Clin Pharmacol Ther; 2001 May; 69(5):286-96. PubMed ID: 11371996
[No Abstract] [Full Text] [Related]
17. Lessons from 60 years of pharmaceutical innovation.
Munos B
Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
[TBL] [Abstract][Full Text] [Related]
18. Rising drug prices drive US manufacturers' revenues, analysis finds.
McCarthy M
BMJ; 2015 Oct; 351():h5376. PubMed ID: 26446098
[No Abstract] [Full Text] [Related]
19. Raising the game.
Nat Biotechnol; 2008 Feb; 26(2):137. PubMed ID: 18259155
[No Abstract] [Full Text] [Related]
20. No immediate pain relief for the pharmaceutical industry.
Ahlborn H; Henderson S; Davies N
Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]